We are live on ! Find out more
NMTR

9 Meters Biopharma
NMTR

Delisted

NMTR was delisted on the 25th of July, 2023.

Back to rankings

39 hedge funds and large institutions have $4.4M invested in 9 Meters Biopharma in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,339% more call options, than puts

Call options by funds: $1.69M | Put options by funds: $49K

47% more capital invested

Capital invested by funds: $3M → $4.4M (+$1.4M)

7% less funds holding

Funds holding: 42 → 39 (-3)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

67% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 12

Holders
39
Holders Change
-3
Holders Change %
-7.14%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
4
Reduced
12
Closed
7
Calls
$1.69M
Puts
$49K
Net Calls
+$1.64M
Net Calls Change
-$56K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$2.08M
2
CIBC Asset Management
CIBC Asset Management
Ontario, Canada
+$61.7K
3
RCM
Requisite Capital Management
Texas
+$28.3K
4
Cerity Partners
Cerity Partners
New York
+$20.2K
5
Mercer Global Advisors
Mercer Global Advisors
Colorado
+$19.3K

Top Sellers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
-$138K
2
Renaissance Technologies
Renaissance Technologies
New York
-$111K
3
Two Sigma Investments
Two Sigma Investments
New York
-$60K
4
RWP
RWA Wealth Partners
Massachusetts
-$48.9K
5
Millennium Management
Millennium Management
New York
-$46.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$473 +$4 +2 +0.6%
PA
27
PSI Advisors
Florida
$417 – – –
MA
28
MCF Advisors
Kentucky
$383 – – –
SIS
29
Strategic Investment Solutions
Illinois
$382 +$519 +275 New
HFM
30
Hartford Financial Management
Connecticut
$278 – – –
BCMLT
31
Beacon Capital Management LLC (Tennessee)
Tennessee
$215 – – –
PNC Financial Services Group
32
PNC Financial Services Group
Pennsylvania
$209 – – –
RFA
33
Register Financial Advisors
Georgia
$139 – – –
TWA
34
TCI Wealth Advisors
Arizona
$70 – – –
Commonwealth Equity Services
35
Commonwealth Equity Services
Massachusetts
$52 -$483 -256 -0.7%
Northwestern Mutual Wealth Management
36
Northwestern Mutual Wealth Management
Wisconsin
$3 – – –
RCM
37
Raleigh Capital Management
North Carolina
$3 – – –
GCP
38
GSA Capital Partners
United Kingdom
– -$138K -109,685 Closed
Two Sigma Investments
39
Two Sigma Investments
New York
– -$60K -47,617 Closed
Hudson Bay Capital Management
40
Hudson Bay Capital Management
Connecticut
– -$31.5K -25,001 Closed
MFG
41
Merit Financial Group
Georgia
– -$31.5K -25,000 Closed
RWP
42
RWA Wealth Partners
Massachusetts
– -$48.9K -21,429 Closed
Rockefeller Capital Management
43
Rockefeller Capital Management
New York
– -$1K -1,000 Closed
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
– +$155 +82 +99%
1
2

NMTR Hedge Fund Activity: Q1 2023 in Review

39 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q1 2023, worth a combined $4.4M — up 47% from $3M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of NMTR and 6 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 4 added.

The largest buyer was Sabby Management, opening a new position worth an estimated $2.08M. The largest seller was GSA Capital Partners, exiting entirely with an estimated $138K sold.

  • 39 institutional investors held 9 Meters Biopharma (NMTR) as of Q1 2023, down from 42 in Q4 2022.
  • Funds reported $4.4M of 9 Meters Biopharma stock for Q1 2023, up 47% quarter-over-quarter.
  • 6 funds opened new 9 Meters Biopharma positions in Q1 2023 and 7 closed out, a net change of -1 holder.
  • The largest 9 Meters Biopharma buyer in Q1 2023 was Sabby Management, an estimated $2.08M added.
  • The largest 9 Meters Biopharma seller in Q1 2023 was GSA Capital Partners, an estimated $138K sold.

Based on aggregated 13F filings for Q1 2023.